Companies:
10,793
total market cap:
$134.277 T
Sign In
๐บ๐ธ
EN
English
$ USD
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
Sleep Number
SNBR
#10179
Rank
$26.97 M
Marketcap
๐บ๐ธ
United States
Country
$1.18
Share price
-30.99%
Change (1 day)
-77.35%
Change (1 year)
๐๏ธ Retail
๐ช Furniture
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
Sleep Number
Quarterly Reports (10-Q)
Financial Year FY2018 Q1
Sleep Number - 10-Q quarterly report FY2018 Q1
Text size:
Small
Medium
Large
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the Quarterly Period Ended
March 31, 2018
Commission File Number: 0-25121
SLEEP NUMBER CORPORATION
(Exact name of registrant as specified in its charter)
Minnesota
41-1597886
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
1001 Third Avenue South
Minneapolis, Minnesota
55404
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code:
(763) 551-7000
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES
ý
NO
o
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). YES
ý
NO
o
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
ý
Accelerated filer
o
Non-accelerated filer
o
(Do not check if a smaller reporting company)
Smaller reporting company
o
Emerging growth company
o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES
o
NO
ý
As of
March 31, 2018
,
36,943,000
shares of the Registrant’s Common Stock were outstanding.
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
INDEX
Page
PART I: FINANCIAL INFORMATION
Item 1.
Financial Statements
(unaudited)
Condensed Consolidated Balance Sheets
2
Condensed Consolidated Statements of Operation
s
3
Condensed Consolidated Statement of Shareholders’ Equity
4
Condensed Consolidated Statements of Cash Flows
5
Notes to Condensed Consolidated Financial Statements
6
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
13
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
21
Item 4.
Controls and Procedures
21
PART II: OTHER INFORMATION
22
Item 1.
Legal Proceedings
22
Item 1A.
Risk Factors
22
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
22
Item 3.
Defaults Upon Senior Securities
23
Item 4.
Mine Safety Disclosures
23
Item 5.
Other Information
23
Item 6.
Exhibits
24
SIGNATURES
25
ii
PART I: FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(unaudited - in thousands, except per share amounts)
March 31,
2018
December 30,
2017
Assets
Current assets:
Cash and cash equivalents
$
2,335
$
3,651
Accounts receivable, net of allowance for doubtful accounts of $548 and $714, respectively
21,798
19,312
Inventories
86,783
84,298
Prepaid expenses
9,339
17,565
Other current assets
22,126
27,665
Total current assets
142,381
152,491
Non-current assets:
Property and equipment, net
204,331
208,646
Goodwill and intangible assets, net
77,042
77,588
Deferred income taxes
1,441
2,625
Other non-current assets
33,506
30,484
Total assets
$
458,701
$
471,834
Liabilities and Shareholders’ Equity
Current liabilities:
Borrowings under revolving credit facility
$
75,800
$
24,500
Accounts payable
116,142
129,194
Customer prepayments
30,179
27,767
Accrued sales returns
19,016
19,270
Compensation and benefits
27,307
34,602
Taxes and withholding
30,658
24,234
Other current liabilities
46,566
46,822
Total current liabilities
345,668
306,389
Non-current liabilities:
Other non-current liabilities
77,036
76,289
Total liabilities
422,704
382,678
Shareholders’ equity:
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding
—
—
Common stock, $0.01 par value; 142,500 shares authorized, 36,943 and 38,813 shares issued and outstanding, respectively
369
388
Additional paid-in capital
—
—
Retained earnings
35,628
88,768
Total shareholders’ equity
35,997
89,156
Total liabilities and shareholders’ equity
$
458,701
$
471,834
See accompanying notes to condensed consolidated financial statements.
2
Index
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(unaudited - in thousands, except per share amounts)
Three Months Ended
March 31,
2018
April 1,
2017
Net sales
$
388,633
$
393,899
Cost of sales
151,156
147,440
Gross profit
237,477
246,459
Operating expenses:
Sales and marketing
171,917
169,266
General and administrative
31,734
33,769
Research and development
6,925
7,596
Total operating expenses
210,576
210,631
Operating income
26,901
35,828
Other expense, net
(525
)
(138
)
Income before income taxes
26,376
35,690
Income tax expense
5,828
11,229
Net income
$
20,548
$
24,461
Basic net income per share:
Net income per share – basic
$
0.54
$
0.57
Weighted-average shares – basic
38,244
42,750
Diluted net income per share:
Net income per share – diluted
$
0.52
$
0.56
Weighted-average shares – diluted
39,347
43,712
See accompanying notes to condensed consolidated financial statements.
3
Index
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Condensed Consolidated Statement of Shareholders’ Equity
(unaudited - in thousands)
Common Stock
Additional
Paid-in
Capital
Retained
Earnings
Total
Shares
Amount
Balance at December 30, 2017
38,813
$
388
$
—
$
88,768
$
89,156
Net income
—
—
—
20,548
20,548
Exercise of common stock options
68
1
856
—
857
Stock-based compensation
211
2
3,082
—
3,084
Repurchases of common stock
(2,149
)
(22
)
(3,938
)
(73,688
)
(77,648
)
Balance at March 31, 2018
36,943
$
369
$
—
$
35,628
$
35,997
See accompanying notes to condensed consolidated financial statements.
4
Index
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(unaudited - in thousands)
Three Months Ended
March 31,
2018
April 1,
2017
Cash flows from operating activities:
Net income
$
20,548
$
24,461
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
15,680
16,205
Stock-based compensation
3,084
3,704
Net gain on disposals and impairments of assets
(70
)
—
Deferred income taxes
1,184
5,663
Changes in operating assets and liabilities:
Accounts receivable
(2,486
)
1,478
Inventories
(2,485
)
8,168
Income taxes
4,762
5,541
Prepaid expenses and other assets
13,894
2,880
Accounts payable
123
(1,394
)
Customer prepayments
2,412
4,443
Accrued compensation and benefits
(7,567
)
11,693
Other taxes and withholding
1,662
(903
)
Other accruals and liabilities
(1,485
)
4,930
Net cash provided by operating activities
49,256
86,869
Cash flows from investing activities:
Purchases of property and equipment
(8,805
)
(13,211
)
Proceeds from sales of property and equipment
70
—
Net cash used in investing activities
(8,735
)
(13,211
)
Cash flows from financing activities:
Repurchases of common stock
(77,648
)
(54,794
)
Net increase in short-term borrowings
35,963
2,369
Proceeds from issuance of common stock
857
460
Debt issuance costs
(1,009
)
—
Net cash used in financing activities
(41,837
)
(51,965
)
Net (decrease) increase in cash, cash equivalents and restricted cash
(1,316
)
21,693
Cash, cash equivalents and restricted cash, at beginning of period
3,651
14,759
Cash, cash equivalents and restricted cash, at end of period
$
2,335
$
36,452
See accompanying notes to condensed consolidated financial statements.
5
Index
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
1. Business and Summary of Significant Accounting Policies
Business & Basis of Presentation
We prepared the condensed consolidated financial statements as of and for the
three months ended
March 31, 2018
of Sleep Number Corporation and 100%-owned subsidiaries (Sleep Number or the Company), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) and they reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position as of
March 31, 2018
and
December 30, 2017
, and the consolidated results of operations and cash flows for the periods presented. Our historical and quarterly consolidated results of operations may not be indicative of the results that may be achieved for the full year or any future period.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with our most recent audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended
December 30, 2017
and other recent filings with the SEC.
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of sales, expenses and income taxes during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates will be reflected in the consolidated financial statements in future periods. Our critical accounting policies consist of stock-based compensation, goodwill and indefinite-lived intangible assets, warranty liabilities and revenue recognition.
The condensed consolidated financial statements include the accounts of Sleep Number Corporation and our 100%-owned subsidiaries. All significant intra-entity balances and transactions have been eliminated in consolidation.
New Accounting Pronouncements
Recently Adopted Accounting Guidance
Adoption of ASC Topic 230,
Restricted Cash
Effective December 31, 2017, we adopted ASC Topic 230,
Restricted Cash
, which requires amounts generally described as restricted cash and restricted cash equivalents be included with cash and cash equivalents when reconciling the total beginning and ending amounts for the periods shown on the statement of cash flows. Amounts for prior periods have been retrospectively adjusted to conform to the current period presentation.
Adoption of ASC Topic 606,
Revenue from Contracts with Customers
On December 31, 2017, we adopted ASC Topic 606,
Revenue from Contracts with Customers,
using the modified retrospective method applied to those contracts which were not completed as of December 30, 2017. Results for reporting periods beginning after December 30, 2017 are presented under the new guidance, while prior period amounts are not restated.
The cumulative effect of the changes made to our consolidated balance sheet as of December 31, 2017 resulting from the adoption of the new revenue guidance was not material and did not impact opening retained earnings. The impact on the timing of net sales for the quarter ended March 31, 2018, as a result of applying the new guidance, was not material.
Practical expedients and exemptions permissible under ASC Topic 606 that we elected are as follows: we do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less; and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
See Note 2,
Revenue Recognition,
for further details regarding our revenue recognition policy.
6
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
Accounting Guidance Issued but Not Yet Adopted as of
March 31, 2018
In February 2016, the FASB issued new guidance on accounting for leases that generally requires most leases to be recognized on the balance sheet. This new guidance is effective for reporting periods beginning after December 15, 2018. The provisions of this new guidance permit us to utilize a prospective approach, with elective reliefs. We are evaluating the effect of the new standard on our consolidated financial statements and related disclosures. We are the lessee under various agreements for facilities and equipment that are currently accounted for as operating leases. This new guidance is effective for us beginning December 30, 2018.
2. Revenue Recognition
We recognize revenue when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenue recognized excludes sales taxes. Amounts billed to customers for delivery and setup are included in net sales. For most products, we require payment before the products or services are delivered to the customer.
Our beds sold with SleepIQ
®
technology contain multiple-performance obligations including the bed and SleepIQ’s hardware and software. We analyze our multiple-performance obligation(s) to determine whether they are distinct and can be separated or whether they must be accounted for as a single performance obligation. We determined that the beds sold with the SleepIQ technology have two performance obligations consisting of: (i) the bed; and (ii) SleepIQ's hardware and software. SleepIQ’s hardware and software are not separable as the hardware and related software are not sold separately and the software is integral to the hardware’s functionality. We determine the transaction price for multiple performance obligations based on their relative standalone selling prices. The performance obligation related to the bed is satisfied at a point in time. The performance obligation related to SleepIQ technology is satisfied over time based on the ongoing access and usage by the customer of software essential to the functionality of SleepIQ technology. The deferred revenue and costs related to SleepIQ technology are recognized on a straight-line basis over the product’s estimated life of
four years
because our inputs are generally expended evenly throughout the performance period. Revenue from goods and services transferred to customers at a point in time accounted for approximately
98%
of our revenues for the three months ended March 31, 2018.
Net sales from each of our channels was as follows (in thousands):
Three Months Ended
March 31,
2018
Retail
$
356,069
Online and phone
27,967
Company-Controlled channel
384,036
Wholesale/Other channel
4,597
Total
$
388,633
At
March 31, 2018
and
December 30, 2017
, we had deferred contract liabilities of
$73 million
and
$73 million
, of which
$31 million
and
$30 million
are included in other current liabilities, respectively, and
$42 million
and
$43 million
are included in other non-current liabilities, respectively, in our consolidated balance sheets. We also had deferred contract assets of
$45 million
and
$43 million
, of which
$18 million
and
$17 million
are included in other current assets, respectively, and
$27 million
and
$26 million
are included in other non-current assets, respectively, in our consolidated balance sheets. During the three months ended
March 31, 2018
, we recognized revenue of
$8 million
that was included in the deferred contract liability balance at the beginning of the period.
7
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
Obligation for Sales Returns
We accept sales returns during a 100-night trial period. Accrued sales returns represents a refund liability for the amount of consideration that we do not expect to be entitled to because it will be refunded to customers. The refund liability estimate is based on historical return rates and is adjusted for any current trends as appropriate. Each reporting period we remeasure the liability to reflect changes in the estimate, with a corresponding adjustment to net sales. The activity in the sales returns liability account was as follows (in thousands):
Three Months Ended
March 31,
2018
April 1,
2017
Balance at beginning of year
$
19,270
$
15,222
Additions that reduce net sales
20,651
21,184
Deductions from reserves
(20,905
)
(18,205
)
Balance at end of period
$
19,016
$
18,201
3. Fair Value Measurements
At
March 31, 2018
and
December 30, 2017
, we had
$5 million
and
$4 million
, respectively, of debt and equity securities that fund our deferred compensation plan and are classified in other non-current assets. We also had corresponding deferred compensation plan liabilities of
$5 million
and
$4 million
at
March 31, 2018
and
December 30, 2017
, respectively, which are included in other non-current liabilities. The majority of the debt and equity securities are Level 1 as they trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis. Unrealized gains/(losses) on the debt and equity securities offset those associated with the corresponding deferred compensation plan liabilities.
4. Inventories
Inventories consisted of the following (in thousands):
March 31,
2018
December 30,
2017
Raw materials
$
4,582
$
6,577
Work in progress
215
170
Finished goods
81,986
77,551
$
86,783
$
84,298
8
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
5. Goodwill and Intangible Assets, Net
Goodwill and Indefinite-Lived Intangible Assets
Goodwill was
$64 million
at
March 31, 2018
and
December 30, 2017
. Indefinite-lived trade name/trademarks totaled
$1.4 million
at
March 31, 2018
and
December 30, 2017
.
Definite-Lived Intangible Assets
The following table provides the gross carrying amount and related accumulated amortization of our definite-lived intangible assets (in thousands):
March 31, 2018
December 30, 2017
Gross Carrying
Amount
Accumulated
Amortization
Gross Carrying
Amount
Accumulated
Amortization
Developed technologies
$
18,851
$
7,251
$
18,851
$
6,705
Trade names/trademarks
101
101
101
101
$
18,952
$
7,352
$
18,952
$
6,806
Amortization expense for the
three months ended
March 31, 2018
and
April 1, 2017
, was
$0.5 million
and
$1.6 million
, respectively.
6. Credit Agreement
Our
$300 million
credit facility is for general corporate purposes and is also utilized to meet our seasonal working capital requirements. The credit agreement provides the lenders with a collateral security interest in substantially all of our assets and those of our subsidiaries and requires us to comply with, among other things, a maximum leverage ratio and a minimum interest coverage ratio. Under the terms of the credit agreement we pay a variable rate of interest and a commitment fee based on our leverage ratio. The credit agreement includes an accordion feature which allows us to increase the amount of the credit facility from
$300 million
to
$450 million
, subject to lenders' approval. The credit agreement matures in
February 2023
. We were in compliance with all financial covenants as of
March 31, 2018
.
The following tables summarizes our borrowings under the credit facility (in thousands):
Three Months Ended
March 31,
2018
December 30,
2017
Outstanding borrowings
$
75,800
$
24,500
Outstanding letters of credit
$
3,450
$
3,150
Additional borrowing capacity
$
220,750
$
125,500
Weighted-average interest rate
3.0
%
3.1
%
9
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
7. Repurchase of Common Stock
Repurchases of our common stock were as follows (in thousands):
Three Months Ended
March 31,
2018
April 1,
2017
Amount repurchased under Board-approved share repurchase program
$
75,000
$
50,000
Amount repurchased in connection with the vesting of employee restricted stock grants
2,648
4,794
Total amount repurchased
$
77,648
$
54,794
As of
March 31, 2018
, the remaining authorization under our Board-approved share repurchase program was
$390 million
. There is no expiration date governing the period over which we can repurchase shares. Any repurchased shares are constructively retired and returned to an unissued status.
The cost of stock repurchases is first charged to additional paid-in capital. Once additional paid-in capital is reduced to zero, any additional amounts are charged to retained earnings.
8. Stock-Based Compensation Expense
Total stock-based compensation expense was as follows (in thousands):
Three Months Ended
March 31,
2018
April 1,
2017
Stock awards
$
2,493
$
3,136
Stock options
591
568
Total stock-based compensation expense
3,084
3,704
Income tax benefit
756
1,248
Total stock-based compensation expense, net of tax
$
2,328
$
2,456
9. Profit Sharing and 401(k) Plan
Under our profit sharing and 401(k) plan, eligible employees may defer up to
50%
of their compensation on a pre-tax basis, subject to Internal Revenue Service limitations. Each pay period, we may make a discretionary contribution equal to a percentage of the employee’s contribution. During the
three months ended
March 31, 2018
and
April 1, 2017
, our contributions, net of forfeitures, were
$1.4 million
and
$1.3 million
, respectively.
10. Other Expense, Net
Other expense, net, consisted of the following (in thousands):
Three Months Ended
March 31,
2018
April 1,
2017
Interest expense
$
(527
)
$
(182
)
Interest income
2
44
Other expense, net
$
(525
)
$
(138
)
10
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
11. Net Income per Common Share
The components of basic and diluted net income per share were as follows (in thousands, except per share amounts):
Three Months Ended
March 31,
2018
April 1,
2017
Net income
$
20,548
$
24,461
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding
38,244
42,750
Dilutive effect of stock-based awards
1,103
962
Diluted weighted-average shares outstanding
39,347
43,712
Net income per share – basic
$
0.54
$
0.57
Net income per share – diluted
$
0.52
$
0.56
For the
three months ended
March 31, 2018
and
April 1, 2017
, anti-dilutive stock-based awards excluded from the diluted net income per share calculations were immaterial.
12. Income Taxes
As a result of the enactment of the Tax Cuts and Jobs Act (TCJA), we recorded a provisional tax benefit of
$1.7 million
in the fourth quarter of 2017 based on our initial analysis of the TCJA using the best information and estimates available. Due to the significant complexity of the TCJA, anticipated further guidance from the U.S. Treasury, the potential for additional guidance from the SEC/ FASB, or other additional information becoming available, our provisional tax benefit may be adjusted during 2018. Our provisional estimate is expected to be finalized no later than the fourth quarter of 2018. Further guidance and additional information regarding the TCJA may also impact our 2018 effective income tax rate, exclusive of any adjustment to the provisional tax benefit.
13. Commitments and Contingencies
Warranty Liabilities
The activity in the accrued warranty liabilities account was as follows (in thousands):
Three Months Ended
March 31,
2018
April 1,
2017
Balance at beginning of year
$
9,320
$
8,633
Additions charged to costs and expenses for current-year sales
3,500
2,718
Deductions from reserves
(3,271
)
(2,049
)
Changes in liability for pre-existing warranties during the current year, including expirations
(77
)
(57
)
Balance at end of period
$
9,472
$
9,245
11
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
Legal Proceedings
We are involved from time to time in various legal proceedings arising in the ordinary course of our business, including primarily commercial, product liability, employment and intellectual property claims. In accordance with generally accepted accounting principles in the United States, we record a liability in our consolidated financial statements with respect to any of these matters when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. With respect to currently pending legal proceedings, we have not established an estimated range of reasonably possible additional losses either because we believe that we have valid defenses to claims asserted against us or the proceeding has not advanced to a stage of discovery that would enable us to establish an estimate. We currently do not expect the outcome of these matters to have a material effect on our consolidated results of operations, financial position or cash flows. Litigation, however, is inherently unpredictable, and it is possible that the ultimate outcome of one or more claims asserted against us could adversely impact our consolidated results of operations, financial position or cash flows. We expense legal costs as incurred.
On January 12, 2015, Plaintiffs David and Katina Spade commenced a purported class action lawsuit in New Jersey state court against Sleep Number alleging that Sleep Number violated New Jersey consumer statutes by failing to provide to purchasing consumers certain disclosures required by the New Jersey Furniture Regulations. It is undisputed that plaintiffs suffered no actual damages or in any way relied upon or were impacted by the alleged omissions. Nonetheless, on behalf of a purported class of New Jersey purchasers of Sleep Number beds and bases, plaintiffs seek to recover a $100 statutory fine for each alleged omission, along with attorneys’ fees and costs. Sleep Number removed the case to the United States District Court for the District of New Jersey, which subsequently granted Sleep Number’s motion to dismiss. Plaintiffs appealed to the United States Court of Appeals for the Third Circuit, which certified two questions of law to the New Jersey Supreme Court relating to whether plaintiffs who have suffered no actual injury may bring claims. The New Jersey Supreme Court accepted the certified questions and on April 16, 2018, ruled in our favor on one of the two questions, holding that a consumer only has standing to bring a claim under the relevant statute if the consumer has been harmed by the defendant's conduct. As a result, we expect that the Third Circuit will uphold the lower Court's dismissal of the case.
12
Index
ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to provide a reader of our consolidated financial statements with a narrative from the perspective of management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. Our MD&A is presented in seven sections:
•
Risk Factors
•
Company Overview
•
Results of Operations
•
Liquidity and Capital Resources
•
Non-GAAP Data
•
Off-Balance-Sheet Arrangements and Contractual Obligations
•
Critical Accounting Policies
Risk Factors
The following discussion and analysis should be read in conjunction with the Condensed Consolidated Financial Statements and the Notes thereto included herein. This quarterly report on Form 10-Q contains certain forward-looking statements that relate to future plans, events, financial results or performance. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “project,” “predict,” “intend,” “potential,” “continue” or the negative of these or similar terms. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections.
These risks and uncertainties include, among others:
•
Current and future general and industry economic trends and consumer confidence;
•
The effectiveness of our marketing messages;
•
The efficiency of our advertising and promotional efforts;
•
Our ability to execute our Company-Controlled distribution strategy;
•
Our ability to achieve and maintain acceptable levels of product and service quality, and acceptable product return and warranty claims rates;
•
Our ability to continue to improve and expand our product line, and consumer acceptance of our products, product quality, innovation and brand image;
•
Industry competition, the emergence of additional competitive products and the adequacy of our intellectual property rights to protect our products and brand from competitive or infringing activities;
•
The potential for claims that our products, processes or trademarks infringe the intellectual property rights of others;
•
Availability of attractive and cost-effective consumer credit options;
•
Shortages in supply due to “just-in-time” manufacturing processes with minimal levels of inventory utilized for some of our products, or due to global shortages of electronic componentry;
•
Our dependence on significant suppliers and our ability to maintain relationships with key suppliers, including several sole-source suppliers;
•
Rising commodity costs and other inflationary pressures;
•
Risks inherent in global sourcing activities, including the potential for shortages in supply;
•
Risks of disruption in the operation of either of our two main manufacturing facilities;
•
Increasing government regulation;
•
Pending or unforeseen litigation and the potential for adverse publicity associated with litigation;
•
The adequacy of our management information systems to meet the evolving needs of our business and existing and evolving regulatory standards applicable to data privacy and security;
•
The costs and potential disruptions to our business related to upgrading our management information systems;
•
The vulnerability of our management information systems to attacks by hackers or other cyber threats that could compromise the security of our systems or disrupt our business; and
•
Our ability to attract, retain and motivate qualified management, executive and other key employees, including qualified retail sales professionals and managers.
Additional information concerning these and other risks and uncertainties is contained under the caption “Risk Factors” in our Annual Report on Form 10-K.
We have no obligation to publicly update or revise any of the forward-looking statements contained in this quarterly report on Form 10-Q.
13
Index
Company Overview
Sleep Number Corporation, based in Minneapolis, Minnesota, was founded in 1987. We are listed on The NASDAQ Stock Market LLC (NASDAQ Global Select Market) under the symbol “SNBR.”
Our mission is to improve lives by individualizing sleep experiences. Our vision is to become one of the world's most beloved brands
by delivering an unparalleled sleep experience. We plan to achieve this by executing our Consumer Innovation Strategy, which includes three significant competitive advantages: proprietary sleep innovations, lifelong customer relationships and exclusive retail distribution.
We have a vertically integrated business model and are the exclusive designer, manufacturer, marketer, retailer and servicer of Sleep
Number® beds. We offer consumers high-quality, individualized sleep solutions and services, including a complete line of Sleep
Number beds, bases and bedding accessories. We are the pioneer in biometric sleep tracking and adjustability. SleepIQ® technology is a proprietary sensor technology that tracks each individual’s sleep and uses algorithms to automatically adjust the comfort level of each sleeper by working directly with our bed’s DualAir™ system. Through daily digital interactions that build lifelong relationships, SleepIQ technology also communicates how you slept and provides insights on what adjustments you can make to optimize your sleep and improve your daily life. Sleep Number also offers FlexFit™ adjustable bases, and Sleep Number pillows, sheets and other bedding products. As a national specialty mattress retailer, we provide customers a cohesive experience across our Sleep Number stores, online at SleepNumber.com or via phone at (800)753-3768.
We are committed to delivering superior shareholder value through three primary drivers of earnings per share growth: increasing
consumer demand, leveraging our business model and deploying capital efficiently. As the sleep innovation leader, we drive
growth through effective brand marketing, our proprietary innovations and a differentiated retail experience.
We generate revenue by marketing our innovations to new and existing customers, and selling products directly to consumers through Stores, Online, Chat and Phone, which we reference as our Company-Controlled channel. We also have a small Wholesale business in the United States.
We are the only vertically integrated bed manufacturer/retailer in the U.S. We have two manufacturing plants that distribute Sleep
Number products. We offer mattress home delivery and installation, and maintain an in-house customer service department. This
integration enables operational synergies and efficiencies, and a strong working capital position. Vertical integration allows us to build
a long-term loyal customer relationship as we service the consumer through the full purchase and ownership cycle. This relationship
with our customer creates a productive cycle of repeat and referral business.
Results of Operations
Quarterly and Year-to-Date Results
Quarterly and year-to-date operating results may fluctuate significantly as a result of a variety of factors, including increases or decreases in sales, the timing, amount and effectiveness of advertising expenditures, changes in sales return rates or warranty experience, timing of investments in growth initiatives and infrastructure, timing of store openings/closings and related expenses, changes in net sales resulting from changes in our store base, the timing of new product introductions and related expenses, the timing of promotional offerings, competitive factors, changes in commodity costs, any disruptions in supplies or third-party service providers, seasonality of retail and bedding industry sales, consumer confidence and general economic conditions. Therefore, our historical results of operations may not be indicative of the results that may be achieved for any future period.
Highlights
Financial highlights for the period ended
March 31, 2018
were as follows:
•
Net sales for the
three months ended
March 31, 2018
decreased
1%
to
$389 million
, compared with
$394 million
for the same period one year ago. The
1%
sales
decrease
resulted from a
3%
comparable sales
decline
in our Company-Controlled channel; partially offset by
2
percentage points (ppt.) of growth from sales generated by
12
net new stores opened in the past 12 months.
•
We expected flat sales performance for the three months ended March 31, 2018, as we continued the transition to our full line of Sleep Number 360® smart beds. In May 2017, we began selling our i7 and i10 smart beds. We launched a third smart bed model (the p6) in December 2017. In April 2018, we launched the Sleep Number 360 p5 and i8 smart beds, our two most popular models. We remain on track to complete the phased implementation of our 360 smart bed line (c2 and c4 models) by the end of the summer of 2018. The Sleep Number 360 smart bed won 13 awards at CES, including being named the Best of Innovation
14
Index
Honoree in the Home Appliance category. It also recently received the 2018 Edison Silver Award for breakthrough product design and innovation in the Wellness Technology category.
•
Sales per store (for stores open at least one year) on a trailing twelve-month basis for the period ended
March 31, 2018
were
$2.4 million
, in line with the prior-year comparable period.
•
Operating income for the quarter totaled
$27 million
, down
$9 million
from
$36 million
for the same period one year ago. Our operating income rate decreased to
6.9%
of net sales, compared with
9.1%
of net sales for the same period last year. The decrease in the operating income rate primarily resulted from temporary inefficiencies associated with operating two supply chains to support the new Sleep Number 360 smart beds and the previous core line of beds and the 1% decrease in net sales.
•
Net income for the quarter was
$21 million
, or
$0.52
per diluted share, compared with
$24 million
, or
$0.56
per diluted share, for the same period one year ago.
•
Cash provided by operating activities totaled
$49 million
for the
three months ended
March 31, 2018
, compared with
$87 million
for the same period one year ago. The largest driver in the year-over-year change in operating cash flows resulted from the timing of performance-based incentive compensation payments. Investing activities for the current-year period included
$9 million
of property and equipment purchases, compared with
$13 million
for the same period last year.
•
At
March 31, 2018
, cash and cash equivalents totaled
$2 million
and we ended the quarter with
$76 million
of borrowings under our
$300 million
revolving credit facility.
•
In the
first
quarter of
2018
, we repurchased
2.1 million
shares of our common stock under our Board-approved share repurchase program at a cost of
$75 million
(an average of
$36.16
per share).
The following table sets forth our results of operations expressed as dollars and percentages of net sales. Figures are in millions, except percentages and per share amounts. Amounts may not add due to rounding differences.
Three Months Ended
March 31,
2018
April 1,
2017
Net sales
$
388.6
100.0
%
$
393.9
100.0
%
Cost of sales
151.2
38.9
%
147.4
37.4
%
Gross profit
237.5
61.1
%
246.5
62.6
%
Operating expenses:
Sales and marketing
171.9
44.2
%
169.3
43.0
%
General and administrative
31.7
8.2
%
33.8
8.6
%
Research and development
6.9
1.8
%
7.6
1.9
%
Total operating expenses
210.6
54.2
%
210.6
53.5
%
Operating income
26.9
6.9
%
35.8
9.1
%
Other expense, net
(0.5
)
(0.1
%)
(0.1
)
0.0
%
Income before income taxes
26.4
6.8
%
35.7
9.1
%
Income tax expense
5.8
1.5
%
11.2
2.9
%
Net income
$
20.5
5.3
%
$
24.5
6.2
%
Net income per share:
Basic
$
0.54
$
0.57
Diluted
$
0.52
$
0.56
Weighted-average number of common shares:
Basic
38.2
42.8
Diluted
39.3
43.7
The percentage of our total net sales, by dollar volume, from each of our channels was as follows:
Three Months Ended
March 31,
2018
April 1,
2017
Company-Controlled channel
98.8
%
98.2
%
Wholesale/Other channel
1.2
%
1.8
%
Total
100.0
%
100.0
%
15
Index
The components of total net sales change, including comparable net sales changes, were as follows:
Three Months Ended
March 31,
2018
April 1,
2017
Sales change rates:
Retail comparable-store sales
(1)
(4
%)
2
%
Online and phone
7
%
18
%
Company-Controlled comparable sales change
(3
%)
3
%
Net opened/closed stores
2
%
10
%
Total Company-Controlled channel
(1
%)
13
%
Wholesale/Other channel
(37
%)
(23
%)
Total net sales change
(1
%)
12
%
(1)
Stores are included in the comparable-store calculations in the 13th full month of operations. Stores that have been remodeled or repositioned within the same shopping center remain in the comparable-store base.
Other sales metrics were as follows:
Three Months Ended
March 31,
2018
April 1,
2017
Average sales per store
(1)
($ in thousands)
$
2,399
$
2,365
Average sales per square foot
(1)
$
899
$
926
Stores > $1 million in net sales
(1)
98
%
97
%
Stores > $2 million in net sales
(1)
60
%
59
%
Average revenue per mattress unit –
Company-Controlled channel
(2)
$
4,421
$
4,053
(1)
Trailing-twelve months for stores included in our comparable-store sales calculation.
(2)
Represents Company-Controlled channel total net sales divided by Company-Controlled channel mattress units.
The number of retail stores operating was as follows:
Three Months Ended
March 31,
2018
April 1,
2017
Beginning of period
556
540
Opened
13
16
Closed
(11
)
(10
)
End of period
558
546
16
Index
Comparison of Three Months Ended
March 31, 2018
with Three Months Ended
April 1, 2017
Net sales
Net sales
decreased
1%
to
$389 million
for the three months ended
March 31, 2018
, compared with
$394 million
for the same period one year ago. The
1%
sales
decrease
resulted from a
3%
comparable sales
decline
in our Company-Controlled channel; partially offset by
2
percentage points (ppt.) of growth from sales generated by
12
net new stores opened in the past 12 months.
We expected flat sales performance for the three months ended March 31, 2018, as we continued the transition to our full line of Sleep Number 360® smart beds. In May 2017, we began selling our i7 and i10 smart beds. We launched a third smart bed model (the p6) in December 2017. In April 2018, we launched the Sleep Number 360 p5 and i8 smart beds, our two most popular models. We remain on track to complete the phased implementation of our 360 smart bed line (c2 and c4 models) by the end of the summer of 2018. The Sleep Number 360 smart bed won 13 awards at CES, including being named the Best of Innovation Honoree in the Home Appliance category. It also recently received the 2018 Edison Silver Award for breakthrough product design and innovations in the Wellness Technology category.
The
$5 million
net sales decrease compared with the same period one year ago was comprised of the following: (i) a $12 million decrease in our Company-Controlled comparable net sales; and (ii) a $2 million decrease in Wholesale/Other channel sales; partially offset by (iii) a $9 million increase resulting from net store openings. Company-Controlled mattress unit sales decreased 9% compared with the prior year. Average revenue per mattress unit in our Company-Controlled channel increased by
9%
to
$4,421
.
Gross profit
Gross profit of
$237 million
decreased
by
$9 million
, or
4%
, compared with
$246 million
for the same period one year ago. The gross profit rate was
61.1%
of net sales for the three months ended
March 31, 2018
, compared with
62.6%
for the prior-year comparable period. The current-year gross profit rate decline of
1.5
ppt. was primarily due to temporary inefficiencies associated with operating two supply chains to support the new Sleep Number 360 smart beds and the previous core line of beds. These inefficiencies or transition costs included higher freight and logistics costs, and supplier transition expenses. In addition, our gross profit rate will fluctuate from quarter to quarter due to a variety of other factors, including warranty expenses, return and exchange costs, and performance-based incentive compensation.
Sales and marketing expenses
Sales and marketing expenses for the three months ended
March 31, 2018
increased to
$172 million
, or
44.2%
of net sales, compared with
$169 million
, or
43.0%
of net sales, for the same period one year ago. The
1.2
ppt. increase in the sales and marketing expense rate was mainly due to the planned investments in media spending which increased by
7%
compared with the prior year.
General and administrative expenses
General and administrative (G&A) expenses totaled
$32 million
, or
8.2%
of net sales, for the three months ended
March 31, 2018
, compared with
$34 million
, or
8.6%
of net sales, in the prior-year period. The
$2 million
decrease
in G&A expenses consisted primarily of the following: (i) a $1.4 million decrease in employee compensation resulting from a year-over-year decrease in performance-based incentive compensation; and (ii) a $0.6 million net decrease in miscellaneous other expenses. The G&A expense rate decreased by
0.4
ppt. in the current-year period compared with the same period one year ago due to the decrease in expenses discussed above, partially offset by the deleveraging impact of the
1%
net sales decrease.
Income tax expense
Income tax expense was
$6 million
for the
three months ended
March 31, 2018
, compared with
$11 million
for the same period one year ago. The effective income tax rate for the
three months ended
March 31, 2018
decreased to
22.1%
from
31.5%
for the prior-year period, reflecting the impact from the Tax Cuts and Jobs Act. Both periods' tax expense and effective tax rates included stock-based compensation excess tax benefits. See Note 12,
Income Taxes
, for further information.
17
Index
Liquidity and Capital Resources
Managing our liquidity and capital resources is an important part of our commitment to deliver superior shareholder value. Our business model, which can operate with minimal working capital, does not require additional capital from external sources to fund operations or organic growth. Our primary sources of liquidity are cash flows provided by operating activities and cash available under our $300 million revolving credit facility. The cash generated from ongoing operations, and cash available under our revolving credit facility are expected to be adequate to maintain operations and fund anticipated expansion and strategic initiatives for the foreseeable future.
As of
March 31, 2018
, cash and cash equivalents totaled
$2 million
compared with
$4 million
as of
December 30, 2017
. Available borrowing capacity under our revolving credit facility was $221 million at March 31, 2018. The
$1.3 million
decrease
in cash, cash equivalents and restricted cash was primarily due to
$49 million
of cash provided by operating activities and a $36 million increase in short-term borrowings, which was more than offset by
$9 million
of cash used to purchase property and equipment and
$78 million
of cash used to repurchase our common stock (
$75 million
under our Board-approved share repurchase program and
$3 million
in connection with the vesting of employee restricted stock grants).
The following table summarizes our cash flows (dollars in millions). Amounts may not add due to rounding differences:
Three Months Ended
March 31,
2018
April 1,
2017
Total cash provided by (used in):
Operating activities
$
49.3
$
86.9
Investing activities
(8.7
)
(13.2
)
Financing activities
(41.8
)
(52.0
)
Net (decrease) increase in cash, cash equivalents and restricted cash
$
(1.3
)
$
21.7
Cash provided by operating activities for the
three months ended
March 31, 2018
was
$49 million
compared with
$87 million
for the
three months ended
April 1, 2017
. Significant components of the year-over-year change in cash provided by operating activities included: (i) a $4 million decrease in net income for the
three months ended
March 31, 2018
, compared with the same period one year ago; (ii) a $19 million fluctuation in accrued compensation and benefits that primarily resulted from year-over-year changes in company-wide performance-based incentive compensation that was accrued and paid in the two comparable periods (lower incentive compensation paid in the first quarter of 2017; lower incentive compensation accrued in the first quarter of 2018); and (iii) an $11 million fluctuation in inventory resulting from temporarily higher than normal inventory levels as of March 31, 2018 to support the roll-out of new products, including our new Sleep Number 360 smart beds.
Net cash
used in
investing activities to purchase property and equipment was
$9 million
for the
three months ended
March 31, 2018
, compared with
$13 million
for the same period one year ago.
Net cash
used in
financing activities was
$42 million
for the
three months ended
March 31, 2018
, compared with
$52 million
for the same period one year ago. During the
three months ended
March 31, 2018
, we repurchased
$78 million
of our stock (
$75 million
under our Board-approved share repurchase program and
$3 million
in connection with the vesting of employee restricted stock awards) compared with
$55 million
(
$50 million
under our Board-approved share repurchase program and
$5 million
in connection with the vesting of employee restricted stock awards) during the same period one year ago. Short-term borrowings increased by
$36 million
during the current-year period primarily due to the increase in borrowings under our revolving credit facility to $76 million, partially offset by a decrease in book overdrafts which are included in the net change in short-term borrowings.
Under our Board-approved share repurchase program, we repurchased
2.1 million
shares at a cost of
$75 million
(an average of
$36.16
per share) during the
three months ended
March 31, 2018
. During the
three months ended
April 1, 2017
, we repurchased
2.2 million
shares at a cost of
$50 million
(an average of
$22.49
per share). Effective as of October 1, 2017, our Board approved an increase in our total remaining share repurchase authorization to $500 million. There is no expiration date governing the period over which we can repurchase shares.
In February 2018, we amended our revolving credit facility to increase our net aggregate availability from $153 million to
$300 million
. We maintained the accordion feature which allows us to increase the amount of the credit facility from
$300 million
to
$450 million
, subject to lenders' approval. There were no other changes to the credit agreement's terms and conditions.
18
Index
As of
March 31, 2018
, we had
$76 million
of borrowings under credit facility and $3 million in outstanding letters of credit. Our available borrowing capacity was $221 million. We were in compliance with all financial covenants. The credit facility matures in
February 2023
. The credit agreement provides the lenders with a collateral security interest in substantially all of our assets and those of our subsidiaries and requires us to comply with, among other things, a maximum leverage ratio and a minimum interest coverage ratio. Under the terms of the credit agreement we pay a variable rate of interest and a commitment fee based on our leverage ratio.
The credit facility is for general corporate purposes and is utilized to meet our seasonal working capital requirements. We currently expect to maintain a modest amount of outstanding borrowings under our credit facility.
We have an agreement with Synchrony Bank to offer qualified customers revolving credit arrangements to finance purchases from us (Synchrony Agreement). The Synchrony Agreement contains certain financial covenants, including a maximum leverage ratio and a minimum interest coverage ratio. As of
March 31, 2018
, we were in compliance with all financial covenants.
Under the terms of the Synchrony Agreement, Synchrony Bank sets the minimum acceptable credit ratings, the interest rates, fees and all other terms and conditions of the customer accounts, including collection policies and procedures, and is the owner of the accounts.
Non-GAAP Data
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure.
Our Adjusted EBITDA calculations are as follows (dollars in thousands):
Three Months Ended
Trailing-Twelve
Months Ended
March 31,
2018
April 1,
2017
March 31,
2018
April 1,
2017
Net income
$
20,548
$
24,461
$
61,164
$
62,909
Income tax expense
5,828
11,229
20,560
28,913
Interest expense
527
182
1,320
887
Depreciation and amortization
15,612
16,152
60,537
59,305
Stock-based compensation
3,084
3,704
15,143
11,899
Asset impairments
—
—
244
59
Adjusted EBITDA
$
45,599
$
55,728
$
158,968
$
163,972
Free Cash Flow
Our “free cash flow” data is considered a non-GAAP financial measure and is not in accordance with, or preferable to, “net cash provided by operating activities,” or GAAP financial data. However, we are providing this information as we believe it facilitates analysis for investors and financial analysts.
The following table summarizes our free cash flow calculations (dollars in thousands):
Three Months Ended
Trailing-Twelve
Months Ended
March 31,
2018
April 1,
2017
March 31,
2018
April 1,
2017
Net cash provided by operating activities
$
49,256
$
86,869
$
134,994
$
174,533
Subtract: Purchases of property and equipment
8,805
13,211
55,423
58,774
Free cash flow
$
40,451
$
73,658
$
79,571
$
115,759
19
Index
Non-GAAP Data
(continued)
Return on Invested Capital (ROIC)
(dollars in thousands)
ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our invested capital. Management believes ROIC is also a useful metric for investors and financial analysts. We compute ROIC as outlined below. Our definition and calculation of ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile net operating profit after taxes (NOPAT) and total invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:
Trailing-Twelve
Months Ended
March 31,
2018
April 1,
2017
Net operating profit after taxes (NOPAT)
Operating income
$
82,987
$
92,580
Add: Rent expense
(1)
74,933
69,217
Add: Interest income
56
128
Less: Depreciation on capitalized operating leases
(2)
(19,266
)
(17,550
)
Less: Income taxes
(3)
(41,486
)
(48,050
)
NOPAT
$
97,224
$
96,325
Average invested capital
Total equity
$
35,997
$
134,151
Less: Cash greater than target
(4)
—
—
Add: Long-term debt
(5)
75,800
—
Add: Capitalized operating lease obligations
(6)
599,464
553,736
Total invested capital at end of period
$
711,261
$
687,887
Average invested capital
(7)
$
688,758
$
692,896
Return on invested capital (ROIC)
(8)
14.1
%
13.9
%
___________________
(1)
Rent expense is added back to operating income to show the impact of owning versus leasing the related assets.
(2)
Depreciation is based on the average of the last five fiscal quarters' ending capitalized operating lease obligations (see note 6) for the respective reporting periods with an assumed thirty-year useful life. This is subtracted from operating income to illustrate the impact of owning versus leasing the related assets.
(3)
Reflects annual effective income tax rates, before discrete adjustments, of
29.9%
and
33.3%
for
2018
and
2017
, respectively.
(4)
Cash greater than target is defined as cash, cash equivalents and marketable debt securities less customer prepayments in excess of $100 million.
(5)
Long-term debt includes existing capital lease obligations, if applicable. In conjunction with increasing our revolving credit facility to $300 million in the first quarter of 2018, we include borrowings under that agreement, including borrowings classified as short term.
(6)
A multiple of eight times annual rent expense is used as an estimate for capitalizing our operating lease obligations. The methodology utilized aligns with the methodology of a nationally recognized credit rating agency.
(7)
Average invested capital represents the average of the last five fiscal quarters' ending invested capital balances.
(8)
ROIC equals NOPAT divided by average invested capital.
Note - Our ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.
20
Index
Off-Balance-Sheet Arrangements and Contractual Obligations
As of
March 31, 2018
, we were not involved in any unconsolidated special purpose entity transactions. Other than our operating leases and
$3.5 million
in outstanding letters of credit, we do not have any off-balance-sheet financing.
There has been no material changes in our contractual obligations, other than in the ordinary course of business, since the end of
fiscal 2017
. See Note 6,
Credit Agreement
, of the Notes to our Condensed Consolidated Financial Statements for information regarding our credit agreement. See our Annual Report on Form 10-K for the fiscal year ended
December 30, 2017
for additional information regarding our other contractual obligations.
Critical Accounting Policies
We discuss our critical accounting policies and estimates in
Management’s Discussion and Analysis of Financial Condition and Results of Operations
in our Annual Report on Form 10-K for the fiscal year ended
December 30, 2017
. Other than the adoption of the new revenue recognition guidance as described in Note 1,
Business and Summary of Significant Accounting Policies and
Note 2
, Revenue Recognition,
there were no other significant changes in our critical accounting policies since the end of
fiscal 2017
.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to changes in market short-term interest rates that will impact our net interest expense. If overall interest rates were one percentage point higher than current rates, net income would decrease by $0.6 million based on the
$76 million
of borrowings under our revolving credit facility at
March 31, 2018
. We do not manage our investment interest-rate volatility risk through the use of derivative instruments.
ITEM 4. CONTROLS AND PROCEDURES
Conclusions Regarding the Effectiveness of Disclosure Controls and Procedures
We maintain disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.
Changes in Internal Controls
There were no changes in our internal control over financial reporting during the fiscal quarter ended
March 31, 2018
, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
21
PART II: OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are involved from time to time in various legal proceedings arising in the ordinary course of our business, including primarily commercial, product liability, employment and intellectual property claims. In accordance with generally accepted accounting principles in the United States, we record a liability in our consolidated financial statements with respect to any of these matters when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. With respect to currently pending legal proceedings, we have not established an estimated range of reasonably possible additional losses either because we believe that we have valid defenses to claims asserted against us or the proceeding has not advanced to a stage of discovery that would enable us to establish an estimate. We currently do not expect the outcome of these matters to have a material effect on our consolidated results of operations, financial position or cash flows. Litigation, however, is inherently unpredictable, and it is possible that the ultimate outcome of one or more claims asserted against us could adversely impact our consolidated results of operations, financial position or cash flows. We expense legal costs as incurred.
On January 12, 2015, Plaintiffs David and Katina Spade commenced a purported class action lawsuit in New Jersey state court against Sleep Number alleging that Sleep Number violated New Jersey consumer statutes by failing to provide to purchasing consumers certain disclosures required by the New Jersey Furniture Regulations. It is undisputed that plaintiffs suffered no actual damages or in any way relied upon or were impacted by the alleged omissions. Nonetheless, on behalf of a purported class of New Jersey purchasers of Sleep Number beds and bases, plaintiffs seek to recover a $100 statutory fine for each alleged omission, along with attorneys’ fees and costs. Sleep Number removed the case to the United States District Court for the District of New Jersey, which subsequently granted Sleep Number’s motion to dismiss. Plaintiffs appealed to the United States Court of Appeals for the Third Circuit, which certified two questions of law to the New Jersey Supreme Court relating to whether plaintiffs who have suffered no actual injury may bring claims. The New Jersey Supreme Court accepted the certified questions and on April 16, 2018, ruled in our favor on one of the two questions, holding that a consumer only has standing to bring a claim under the relevant statute if the consumer has been harmed by the defendant's conduct. As a result, we expect that the Third Circuit will uphold the lower Court's dismissal of the case.
ITEM 1A. RISK FACTORS
Our business, financial condition and operating results are subject to a number of risks and uncertainties, including both those that are specific to our business and others that affect all businesses operating in a global environment. Investors should carefully consider the information in this report under the heading, “
Management’s Discussion and Analysis of Financial Condition and Results of Operations
” and also the information under the heading, “
Risk Factors
” in our most recent Annual Report on Form 10-K. The risk factors discussed in the Annual Report on Form 10-K and in this Quarterly Report on Form 10-Q do not identify all risks that we face because our business operations could also be affected by additional risk factors that are not presently known to us or that we currently consider to be immaterial to our operations.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
(a) – (b)
Not applicable.
(c)
Issuer Purchases of Equity Securities
Fiscal Period
Total
Number
of Shares
Purchased
(1)(2)
Average
Price
Paid
per Share
Total Number
of Shares
Purchased as
Part of
Publicly
Announced
Plans or
Programs
(1)
Approximate
Dollar Value
of Shares that
May Yet Be
Purchased
Under the
Plans or
Programs
(3)
December 31, 2017 through January 27, 2018
332,867
$
38.50
330,605
$
452,271,000
January 28, 2018 through February 24, 2018
471,269
36.32
468,206
435,266,000
February 25, 2018 through March 31, 2018
1,344,896
35.48
1,275,065
390,000,000
Total
2,149,032
$
36.13
2,073,876
$
390,000,000
(1)
Under our Board-approved $500 million share repurchase program, we repurchased
2,073,876
shares of our common stock at a cost of
$75 million
(based on trade dates) during the three months ended
March 31, 2018
.
(2)
In connection with the vesting of employee restricted stock grants, we also repurchased
75,156
shares of our common stock at a cost of
$3 million
during the three months ended
March 31, 2018
.
(3)
There is no expiration date governing the period over which we can repurchase shares under our Board-approved share repurchase program. Any repurchased shares are constructively retired and returned to an unissued status.
22
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Not applicable.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
Not applicable.
23
Index
ITEM 6. EXHIBITS
Exhibit
Number
Description
Method of Filing
31.1
Certification of CEO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Filed herewith
31.2
Certification of CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Filed herewith
32.1
Certification of CEO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
Furnished herewith
32.2
Certification of CFO pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
Furnished herewith
101
The following financial information from the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2018, filed with the SEC on May 1, 2018, formatted in eXtensible Business Reporting Language: (i) Condensed Consolidated Balance Sheets as of March 31, 2018 and December 30, 2017; (ii) Condensed Consolidated Statements of Operations for the three months ended March 31, 2018 and April 1, 2017; (iii) Condensed Consolidated Statement of Shareholders' Equity for the three months ended March 31, 2018; (iv) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2018 and April 1, 2017; and (v) Notes to Condensed Consolidated Financial Statements.
Filed herewith
24
Index
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SLEEP NUMBER CORPORATION
(Registrant)
Dated:
May 2, 2018
By:
/s/ Shelly R. Ibach
Shelly R. Ibach
Chief Executive Officer
(principal executive officer)
By:
/s/ Robert J. Poirier
Robert J. Poirier
Chief Accounting Officer
(principal accounting officer)
25